Hospital Volume and Outcome after Bilateral Internal Mammary Artery Grafting
Keywords:Coronary artery bypass grafting, bilateral, internal mammary artery, sternal wound infection
Background: Bilateral internal mammary artery (BIMA) grafting largely is underutilized in patients undergoing coronary artery bypass grafting (CABG), partly because of the perceived increased complexity of
Aims: In this study, we evaluated whether BIMA grafting can safely be performed also in centers, where this revascularization strategy infrequently is adopted.
Methods: Out of 6,783 patients from the prospective multicenter E-CABG study, who underwent isolated non-
emergent CABG from January 2015 to December 2016, 2,457 underwent BIMA grafting and their outcome was evaluated in this analysis.
Results: The mean number of BIMA grafting per center was 82 cases/year and hospitals were defined as high or low volume, according to this cutoff value. Six hospitals were considered as centers with a high volume of BIMA grafting (no. of procedures ranging from 120 to 267/year; overall: 2,156; prevalence: 62.2%) and nine hospitals as centers with a low volume of BIMA grafting (no. of procedures ranging from 2 to 39/year; overall: 301; prevalence: 9.1%). Multilevel mixed-effects regression analysis showed that the low- and high-volume cohorts had similar outcomes. Propensity score one-to-one matching analysis of 292 pairs showed that the low-volume cohort had a significantly shorter intensive care unit stay (2.2 ± 2.3 versus 2.9 ± 4.8 days, P = .020). The rates of in-hospital death (1.0% versus 0.3%, P = .625), deep sternal wound infection/mediastinitis (3.8% versus 3.1%, P = .824), and 1-year survival (98.1% versus 99.7%, P = .180) as well as other outcomes were similar between the high- and
Conclusions: BIMA grafting can be safely performed also in centers in which this revascularization strategy is infrequently performed.
Benedetto U, Lau C, Caputo M, Kim L, Feldman DN, Ohmes LB, et al. 2018. Comparison of outcomes for off-pump versus on-pump coronary artery bypass grafting in low-volume and high-volume centers and by low-volume and high-volume surgeons. Am J Cardiol 121:552-557.
Benussi B, Gatti G, Gripshi F, Biondi F, Porcari A, Ruggiero D, et al. 2019. Clinical Validation of a Coronary Surgery Technique That Minimizes Aortic Manipulation. Ann Thorac Surg 107:1166-1173.
Biancari F, Ruggieri VG, Perrotti A, Svenarud P, Dalén M, Onorati F, et al. 2015. European multicenter study on coronary artery bypass grafting (E-CABG registry): study protocol for a prospective clinical registry and proposal of classification of postoperative complications. J Cardiothorac Surg 10:90.
Dalén M, Ivert T, Holzmann MJ, Sartipy U. 2014. Bilateral versus single internal mammary coronary artery bypass grafting in Sweden from 1997-2008. PLoS One 9:e86929.
Dorman MJ, Kurlansky PA, Traad EA, Galbut DL, Zucker M, Ebra G. 2012. Bilateral internal mammary artery grafting enhances survival in diabetic patients. A 30-year follow-up propensity-score matched cohorts. Circulation 126:2935-2942.
Garatti A, Castelvecchio S, Canziani A, Corain L, Generali T, Mossuto E, et al. 2014. Long-term results of sequential vein coronary artery bypass grafting compared with totally arterial myocardial revascularization: a propensity score-matched follow-up study. Eur J Cardiothorac Surg 46:1006-13.
Gatti G, Dell'Angela L, Barbati G, Benussi B, Forti G, Gabrielli M, et al. 2016. A predictive scoring system for deep sternal wound infection after bilateral internal thoracic artery grafting. Eur J Cardiothorac Surg 49:910-917.
Gray AM, Murphy J, Altman DG, Benedetto U, Campbell H, Flather M, et al. 2017. One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularization Trial. Heart.
Iribarne A, Goodney PP, Flores AM, DeSimone J, DiScipio AW, et al. 2017. National trends and geographic variation in bilateral internal mammary artery use in the United States. Ann Thorac Surg 104:1902-1907.
Iribarne A, Schmoker JD, Malenka DJ, Leavitt BJ, McCullough JN, Weldner PW, et al. 2017. Does use of bilateral internal mammary artery grafting reduce long-term risk of repeat coronary revascularization? A multicenter analysis. Circulation 136:1676-1685.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. 2013. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl 3:1-150.
LaPar DJ, Crosby IK, Rich JB, Quader MA, Speir AM, Kern JA, et al. 2015. Bilateral internal mammary artery use for coronary artery bypass grafting remains underutilized: a propensity-matched multi-institution analysis. Ann Thorac Surg 100:8-14.
Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM. 2004. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 78:2005-12.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. 1999. Guideline for prevention of surgical site infection. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250-278.
Pasrija C, Ghoreishi M, Shah A, Rouse M, Gammie JS, Kon ZN, Taylor BS. 2018. Bilateral internal mammary artery use can be safely taught without increasing morbidity or mortality. Ann Thorac Surg 105:76-82.
Pevni D, Ben-Gal Y, Mohr R, Ganiel A, Paz Y, Kramer A, et al. 2017. One or two internal thoracic grafts? Long-term follow-up of 957 off-pump coronary bypass surgeries. Ann Thorac Surg 104:70-77.
Taggart DP, Benedetto U, Gerry S, Altman DG, Gray AM, Lees B, et al. 2019. Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med 380:437-446.
Weiss AJ, Zhao S, Tian DH, Taggart DP, Yan TD. 2013. A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting. Ann Cardiothorac Surg 2:390-400.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).